Valuation: ALTEOGEN Inc.

Capitalization 23,78100Cr 1.72TCr 1.47TCr 1.37TCr 1.28TCr 2.36TCr 1,48000Cr 2.62TCr 17TCr 6.27TCr 69TCr 6.46TCr 6.32TCr 2,53900Cr P/E ratio 2025 *
326x
P/E ratio 2026 * 48.2x
Enterprise value 2.36TCr 1.71Cr 1.46Cr 1.36Cr 1.27Cr 2.34Cr 147.05Cr 2.61Cr 16Cr 6.23Cr 69Cr 6.41Cr 6.28Cr 252.28Cr EV / Sales 2025 *
115x
EV / Sales 2026 * 42.5x
Free-Float
72.75%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.37%
1 week+6.71%
Current month+19.62%
1 month+15.43%
3 months+14.99%
6 months+44.72%
Current year+43.78%
More quotes
1 week 4,13,000
Extreme 413000
4,53,000
1 month 3,71,000
Extreme 371000
4,53,000
Current year 2,98,000
Extreme 298000
4,59,500
1 year 2,42,000
Extreme 242000
4,59,500
3 years 27,875
Extreme 27875
4,59,500
5 years 27,875
Extreme 27875
4,59,500
10 years 3,590.28
Extreme 3590.2778
4,59,500
More quotes
Manager TitleAgeSince
Chief Executive Officer 70 13/05/2008
Comptroller/Controller/Auditor 59 29/03/2021
Corporate Officer/Principal 59 -
Director TitleAgeSince
Chairman 70 13/05/2008
Director/Board Member 69 29/03/2021
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.37%+6.71%+63.30%+724.07% 1.72TCr
+3.75%+1.92%-18.76%-16.24% 7.67TCr
+0.50%+6.04%-48.13%-4.72% 6.03TCr
-1.42%+4.20%+26.61%+26.30% 5.37TCr
+0.03%+1.47%+19.99%+106.71% 3.83TCr
-0.82%+2.29%-42.14%-37.88% 1.95TCr
+3.72%+3.22%+117.39%+130.66% 1.79TCr
-0.04%-.--%+68.78%+135.69% 1.4TCr
+2.03%+4.03%+9.93%-12.12% 1.35TCr
-2.29%+9.93%-72.94%-79.45% 1.27TCr
Average +0.58%+2.73%+12.40%+97.30% 3.24TCr
Weighted average by Cap. +0.92%+2.39%+1.20%+57.91%
See all sector performances

Financials

2025 *2026 *
Net sales 21TCr 15Cr 13Cr 12Cr 11Cr 20Cr 1.28TCr 23Cr 142.75Cr 54Cr 597.99Cr 56Cr 55Cr 2.19TCr 54TCr 39Cr 34Cr 31Cr 29Cr 54Cr 3.39TCr 60Cr 378.23Cr 143.38Cr 1.58TCr 147.69Cr 144.66Cr 5.81TCr
Net income 7.3TCr 5.28Cr 4.52Cr 4.21Cr 3.93Cr 7.23Cr 454.37Cr 8.06Cr 51Cr 19Cr 212.58Cr 20Cr 19Cr 779.51Cr 49TCr 36Cr 31Cr 29Cr 27Cr 49Cr 3.08TCr 55Cr 343.75Cr 130.31Cr 1.44TCr 134.23Cr 131.47Cr 5.28TCr
Net Debt -16TCr -11Cr -9.62Cr -8.95Cr -8.36Cr -15Cr -966.31Cr -17Cr -107.92Cr -41Cr -452.09Cr -42Cr -41Cr -1.66TCr -65TCr -47Cr -40Cr -38Cr -35Cr -64Cr -4.05TCr -72Cr -452.2Cr -171.42Cr -1.89TCr -176.57Cr -172.94Cr -6.95TCr
More financial data * Estimated data
Logo ALTEOGEN Inc.
Alteogen Inc. is a Korea-based company mainly engaged in the research and development of biopharmaceuticals. The Company operates biobetter business segment, which develops protein pharmaceuticals and cancer therapies, and bio similar business segment, which develops bio similar and animal medicines. The Company mainly provides growth hormone, herceptin, humira, antibodies, animal drugs and others.
Employees
155
More about the company
Date Price Change Volume
14/25/14 4,45,000.00 +1.37% 2,67,180
11/25/11 4,39,000.00 -2.23% 3,52,929
10/25/10 4,49,000.00 +6.02% 9,18,273
09/25/09 4,23,500.00 +1.07% 3,73,649
08/25/08 4,19,000.00 +0.48% 4,00,000

End-of-day quote Korea S.E., July 14, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
CCC
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4,45,000.00KRW
Average target price
5,65,000.00KRW
Spread / Average Target
+26.97%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A196170 Stock